Caesarean and Corticotherapy

Sponsor
University Hospital, Strasbourg, France (Other)
Overall Status
Completed
CT.gov ID
NCT00446953
Collaborator
(none)
200
5
2
81
40
0.5

Study Details

Study Description

Brief Summary

Comparison of two randomized group :
  • caesarean section planned at 38 weeks after 2 antenatal injections of 12 mg of betamethasone 48 h before.

  • caesarean section planned at 39 weeks without corticosteroid.

The aim is to demonstrate that programming caesarean section at 38 weeks of pregnancy, after antenatal corticosteroid, allows to avoid caesarean section in emergency (because of a labour before 39 weeks), without increasing the neonatal respiratory distress rate.

Condition or Disease Intervention/Treatment Phase
Phase 4

Study Design

Study Type:
Interventional
Actual Enrollment :
200 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Interest in Programming Caesarean Section at 38 Weeks of Pregnancy With Antenatal Betamethasone to Prevent Neonatal Respiratory Distress and to Avoid Emergency Caesarean Section Before Planned Date.
Study Start Date :
Feb 1, 2007
Actual Primary Completion Date :
Oct 1, 2013
Actual Study Completion Date :
Nov 1, 2013

Arms and Interventions

Arm Intervention/Treatment
Experimental: 1

2x 12 mg betamethazone

Drug: betamethasone
2x12 mg betamethazone c-section at 38 weeks

Placebo Comparator: 2

no drugs

Other: placebo
c-section at 39 weeks

Outcome Measures

Primary Outcome Measures

  1. Neonatal respiratory distress [15 days]

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • woman who needs elective caesarean section
Exclusion Criteria:
  • multiple pregnancy

  • toxaemia

  • rhesus immunization

  • fetal infection

  • maternal gastro-duodenal ulcer

  • mother HIV+

  • prior injection of corticosteroid during the pregnancy

Contacts and Locations

Locations

Site City State Country Postal Code
1 Le Parc Centre pour la Mère et l'Enfant Colmar France 68000
2 Centre Hospitalier de Haguenau Haguenau France 67504
3 Hôpital de Hasenrain Mulhouse France 68051
4 Cmco-Sihcus Schiltigheim France 67303
5 Hôpital de Hautepierre Strasbourg France 67000

Sponsors and Collaborators

  • University Hospital, Strasbourg, France

Investigators

  • Principal Investigator: Bruno Langer, MD, Les Hôpitaux Universitaires de Strasbourg

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University Hospital, Strasbourg, France
ClinicalTrials.gov Identifier:
NCT00446953
Other Study ID Numbers:
  • 3740
First Posted:
Mar 13, 2007
Last Update Posted:
Oct 14, 2015
Last Verified:
Sep 1, 2013
Keywords provided by University Hospital, Strasbourg, France
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 14, 2015